About SynZeal
SynZeal is a Healthcare company based in Ahmedabad (India) founded in 2011. It develops pharmaceutical reference standards, impurities, and peptides for research. It operates on a B2B and D2C model. The company has 333 employees. Its website synzeal.com draws about 28 thousand monthly visits. Its Indian entity Synzeal Research Private Limited reported revenue of ₹144 Cr. SynZeal offers products and services including Pharmaceutical Reference Standards, Impurities, Peptides, and API Reference Standards. Its focus areas include Pharmaceutical Tech, Reference Standards, API Impurities and Life Sciences.
Company details
SynZeal specializes in creating pharmacopeial and non-pharmacopeial pharmaceutical reference standards, including drug metabolites and stable isotope-labelled compounds. They offer custom synthesis of complex organic molecules and peptides from gram to kilogram scales. Based in Ahmedabad, India, and Brantford, Canada, they serve pharmaceutical companies for drug development, analytical validation, and quality control applications.
- Headquarters Ahmedabad, India
- Employees 333
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website synzeal.com
- Social X Facebook
- Legal Name Synzeal Research Private Limited
- Date of Incorporation 20 Nov, 2014
- Jurisdiction Bavla, Gujarat, India
- Annual Revenue₹144 Cr
FY 2025 · +19% YoY
- Net Profit₹35.43 Cr
FY 2025 · 25% margin
- EBITDA₹70.61 Cr
FY 2025 · 49% margin
- Employee Count333
Associated legal entities of SynZeal
SynZeal operates through Synzeal Research Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Synzeal Research Private Limited CIN U73200GJ2014PTC081295 | Active | 20 Nov 2014 | Bavla, Gujarat | ₹144 Cr | 333 | 4 | View details |
Products & Services of SynZeal
SynZeal offers a comprehensive portfolio of products and services, including Pharmaceutical Reference Standards, Impurities, Peptides, and API Reference Standards.
High-quality standards for drug development and testing purposes.
Reference impurities for pharmaceutical quality control.
Custom synthesized peptides for research applications.
Standards for active pharmaceutical ingredients analysis.
Board of directors of Synzeal Research Private Limited (SynZeal)
Synzeal Research Private Limited is the primary company behind SynZeal. The board of Synzeal Research Private Limited currently have 4 directors; the longest-serving is Rameshbhai Maghabhai Patel, appointed in 2014. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rameshbhai Maghabhai Patel DIN 06998958 | Director | 20 Nov 2014 | 11 yrs 11 mo | Synzeal Research Private Limited |
| Shailesh M Patel DIN 06998903 | Director | 20 Nov 2014 | 11 yrs 11 mo | Synzeal Research Private Limited |
| Jitendra Chhaganbhai Kaila DIN 06998933 | Managing Director | 20 Nov 2014 | 11 yrs 11 mo | Synzeal Research Private Limited |
| Maghabhai Haribhai Patel DIN 07823226 | Director | 01 May 2017 | 9 yrs 5 mo | Synzeal Research Private Limited |
People of SynZeal
4 people are tracked at SynZeal (1 in leadership, 3 in team); the tracked headcount is 333.
| Name | Role | Group |
|---|---|---|
| Director | Leadership | |
Dr. Pravin K. Jha | Senior Manager-peptide R&d | Team |
Kamal Parmar | Assistant Manager | Team |
Dr. Ganesh S. Ghotekar | Process Development Scientist(r&d) | Team |
Complete people profiles for SynZeal
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of SynZeal
Figures of Synzeal Research Private Limited, the primary company behind SynZeal, for FY 2025. Revenue was ₹144 Cr (+19% year on year). Net profit was ₹35.43 Cr (25% margin). EBITDA was ₹70.61 Cr (49% margin). Revenue has grown at a compounded annual rate of +21% over three years and +28% over five years.
- ₹144 CrRevenue · FY 2025 · +19% YoY
- ₹35.43 CrNet profit · 25% margin
- ₹70.61 CrEBITDA · 49% margin
- ₹77.7 LakhPaid-up capital
- 333Employees (provident fund records)
- +21%Revenue CAGR, 3 years
- +28%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Synzeal Research Private Limited are on its company page.
Detailed financial statements for SynZeal
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of SynZeal
The website of SynZeal (synzeal.com) receives about 28.2K visits a month.
- Monthly visits28.2K
▲ 4% vs previous month
Websites whose visitors overlap most with SynZeal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| clearsynth.com | 100% | 20.6K | #1,332,084 | View details | |
| molbase.com | 98% | 32.2K | #982,047 | View details | |
| lgcstandards.com | 80% | 228.5K | #179,043 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SynZeal
SynZeal was founded in 2011.
SynZeal is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
SynZeal has 333 employees.
The primary company behind SynZeal, Synzeal Research Private Limited, reported revenue of ₹144 Cr for FY 2025, up 19% year on year.
SynZeal specializes in creating pharmacopeial and non-pharmacopeial pharmaceutical reference standards, including drug metabolites and stable isotope-labelled compounds. They offer custom synthesis of complex organic molecules and peptides from gram to kilogram scales. Based in Ahmedabad, India, and Brantford, Canada, they serve pharmaceutical companies for drug development, analytical validation, and quality control applications.
SynZeal offers Pharmaceutical Reference Standards, Impurities, Peptides, and API Reference Standards.
SynZeal operates through Synzeal Research Private Limited.
The legal entities of SynZeal currently have 4 directors, including Maghabhai Haribhai Patel, Rameshbhai Maghabhai Patel, Shailesh M Patel and others.